Apures Co., Ltd. (XKON:149300)
South Korea · Delayed Price · Currency is KRW 36.00
-1.00 (-2.70%)
At close: Mar 6, 2026
Apures Market Cap
Apures has a market cap or net worth of 1.68 billion as of March 9, 2026. Its market cap has decreased by -82.76% in one year.
Market Cap
1.68B
Enterprise Value
n/a
Revenue
517.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.00
Market Cap Chart
Since September 3, 2019, Apures's market cap has decreased from 69.02B to 1.68B, a decrease of -97.56%. That is a compound annual growth rate of -43.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.64B | 56.52% |
| Dec 30, 2025 | 1.05B | -87.59% |
| Dec 30, 2024 | 8.43B | -32.29% |
| Dec 28, 2023 | 12.45B | -58.23% |
| Dec 29, 2022 | 29.82B | -55.02% |
| Dec 30, 2021 | 66.29B | -15.40% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 33.33B |
| ADBiotech | 30.86B |
| MOA Life Plus | 25.38B |
| Moogene Medi | 20.15B |
| Plumbline Life Sciences | 18.69B |
| OLIPASS | 8.40B |
| Angiolab | 8.26B |